KPRX Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The products pipeline of the company includes KIO-101, KIO-201, KIO-301, and KIO-102

$1.39  0.00 (0.00%)
As of 12/02/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  07/27/2015
Outstanding shares:  12,653,054
Average volume:  355,432
Market cap:   $17,587,745
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -7.28
PB ratio:   1.01
PS ratio:   0.00
Return on equity:   -60.14%
Net income %:   -86,513.87%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy